NoamKopmarMD

Internal Medicine • Seattle, WA

Physician

Join to view full profile

Dr. Kopmar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kopmar's full profile

Already have an account?

Office
1959 Ne Pacific St
Room Bb-527
Seattle, WA 98195
Phone+1 206-543-3605

Education & Training

University of WashingtonResidency, Internal Medicine, 2015 - 2018
Ben Gurion University of the NegevClass of 2015

Certifications & Licensure

WA State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms Start of enrollment: 2020 May 08
Terminated
Phase 1

Publications & Presentations

PubMed

14 citations
How I prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia.
Noam E Kopmar, Ryan D Cassaday
Blood. 2023-03-23
105 citations
H/ACA Small RNA Dysfunctions in Disease Reveal Key Roles for Noncoding RNA Modifications in Hematopoietic Stem Cell Differentiation
Cristian Bellodi, Mary McMahon, Adrian Contreras, Dayle Juliano, Noam Kopmar
Cell Reports. 2013-05-30
228 citations
rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells.
Karen Jack, Cristian Bellodi, Dori M. Landry, Rachel O. Niederer, Arturas Meskauskas
Molecular Cell. 2011-11-18

Press Mentions

Fred Hutch at ASCO: New Insights on Financial Toxicity, Combination Therapies for Cancer and the Need for Targeted Breast Cancer Therapies in UgandaMay 26th, 2023
‘Exciting’ Research Spotlights CAR-t’s Evolving Role in Blood Cancer TreatmentFebruary 22nd, 2023
Fred Hutch Experts Highlight Research on Cancer Treatment Advances, Survivorship and Precision Oncology at ASCOJune 6th, 2023